303 related articles for article (PubMed ID: 28850801)
1. Spasmodic Dysphonia: A Review. Part 1: Pathogenic Factors.
Hintze JM; Ludlow CL; Bansberg SF; Adler CH; Lott DG
Otolaryngol Head Neck Surg; 2017 Oct; 157(4):551-557. PubMed ID: 28850801
[TBL] [Abstract][Full Text] [Related]
2. Spasmodic Dysphonia: A Review. Part 2: Characterization of Pathophysiology.
Hintze JM; Ludlow CL; Bansberg SF; Adler CH; Lott DG
Otolaryngol Head Neck Surg; 2017 Oct; 157(4):558-564. PubMed ID: 28850796
[TBL] [Abstract][Full Text] [Related]
3. Movement Disorders and Voice.
Snow G; Guardiani E
Otolaryngol Clin North Am; 2019 Aug; 52(4):759-767. PubMed ID: 31076164
[TBL] [Abstract][Full Text] [Related]
4. Validation of a telephone screening tool for spasmodic dysphonia and vocal fold tremor.
Johnson DM; Hapner ER; Klein AM; Pethan M; Johns MM
J Voice; 2014 Nov; 28(6):711-5. PubMed ID: 24962230
[TBL] [Abstract][Full Text] [Related]
5. Identification of symptoms for spasmodic dysphonia and vocal tremor: a comparison of expert and nonexpert judges.
Barkmeier JM; Case JL; Ludlow CL
J Commun Disord; 2001; 34(1-2):21-37. PubMed ID: 11322567
[TBL] [Abstract][Full Text] [Related]
6. Spasmodic dysphonia: a laryngeal control disorder specific to speech.
Ludlow CL
J Neurosci; 2011 Jan; 31(3):793-7. PubMed ID: 21248101
[TBL] [Abstract][Full Text] [Related]
7. Spasmodic dysphonia: let's look at that again.
Murry T
J Voice; 2014 Nov; 28(6):694-9. PubMed ID: 24972536
[TBL] [Abstract][Full Text] [Related]
8. Vocal Parameters and Self-Perception in Individuals With Adductor Spasmodic Dysphonia.
Rojas GVE; Ricz H; Tumas V; Rodrigues GR; Toscano P; Aguiar-Ricz L
J Voice; 2017 May; 31(3):391.e7-391.e18. PubMed ID: 27866691
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic laser thyroarytenoid myoneurectomy in patients with adductor spasmodic dysphonia: a pilot study on long-term outcome on voice quality.
Tsuji DH; Takahashi MT; Imamura R; Hachiya A; Sennes LU
J Voice; 2012 Sep; 26(5):666.e7-12. PubMed ID: 21940146
[TBL] [Abstract][Full Text] [Related]
10. Interarytenoid muscle botox injection for treatment of adductor spasmodic dysphonia with vocal tremor.
Kendall KA; Leonard RJ
J Voice; 2011 Jan; 25(1):114-9. PubMed ID: 20137891
[TBL] [Abstract][Full Text] [Related]
11. Pharyngeal Dystonia Mimicking Spasmodic Dysphonia.
Shi LL; Simpson CB; Hapner ER; Jinnah HA; Johns MM
J Voice; 2018 Mar; 32(2):234-238. PubMed ID: 28651822
[TBL] [Abstract][Full Text] [Related]
12. Spasmodic Dysphonia.
Chen DW; Ongkasuwan J
Int Ophthalmol Clin; 2018; 58(1):77-87. PubMed ID: 29239880
[No Abstract] [Full Text] [Related]
13. Findings of multiple muscle involvement in a study of 214 patients with laryngeal dystonia using fine-wire electromyography.
Klotz DA; Maronian NC; Waugh PF; Shahinfar A; Robinson L; Hillel AD
Ann Otol Rhinol Laryngol; 2004 Aug; 113(8):602-12. PubMed ID: 15330138
[TBL] [Abstract][Full Text] [Related]
14. Refractory Dysphonia Due to Isolated Cricothyroid Muscle Dystonia.
Kraft S; Childes J; Hillel A; Schindler J
J Voice; 2016 Jul; 30(4):501-5. PubMed ID: 26239970
[TBL] [Abstract][Full Text] [Related]
15. Laryngeal dystonia gravidarum: sudden onset of adductor spasmodic dysphonia in pregnancy.
Ankola A; Sulica L; Murry T
Laryngoscope; 2013 Dec; 123(12):3127-30. PubMed ID: 23712421
[TBL] [Abstract][Full Text] [Related]
16. A separation of innate and learned vocal behaviors defines the symptomatology of spasmodic dysphonia.
Guiry S; Worthley A; Simonyan K
Laryngoscope; 2019 Jul; 129(7):1627-1633. PubMed ID: 30582159
[TBL] [Abstract][Full Text] [Related]
17. Central voice production and pathophysiology of spasmodic dysphonia.
Mor N; Simonyan K; Blitzer A
Laryngoscope; 2018 Jan; 128(1):177-183. PubMed ID: 28543038
[TBL] [Abstract][Full Text] [Related]
18. Bilateral Posterior Cricoarytenoid Myoneurectomy for Abductor Spasmodic Dysphonia.
Benito DA; Ferster APO; Sataloff RT
J Voice; 2020 Jan; 34(1):127-129. PubMed ID: 30174222
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiology and treatment of muscle tension dysphonia: a review of the current knowledge.
Van Houtte E; Van Lierde K; Claeys S
J Voice; 2011 Mar; 25(2):202-7. PubMed ID: 20400263
[TBL] [Abstract][Full Text] [Related]
20. Differences in botulinum toxin dosing between patients with adductor spasmodic dysphonia and essential voice tremor.
Orbelo DM; Duffy JR; Hughes Borst BJ; Ekbom D; Maragos NE
J Voice; 2014 Jan; 28(1):123-7. PubMed ID: 24080335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
